CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4 | -100.0% | 15,300 | -87.5% | 0.00% | -98.4% |
| Q4 2021 | $2,278,000 | +86.3% | 122,000 | +36.5% | 0.06% | +55.0% |
| Q3 2021 | $1,223,000 | -5.3% | 89,400 | -0.7% | 0.04% | 0.0% |
| Q2 2021 | $1,291,000 | +517.7% | 90,000 | -6.0% | 0.04% | +263.6% |
| Q1 2021 | $209,000 | -66.3% | 95,700 | -12.2% | 0.01% | -38.9% |
| Q4 2020 | $621,000 | – | 109,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |